Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1aCondition 1b
37percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both5%Freund's incomplete adjuvant (200 ul) 70201Freund's incomplete adjuvant (200 ul)
37post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both14dFreund's incomplete adjuvant (200 ul) 70202Freund's incomplete adjuvant (200 ul)
10percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both100%squalene (200 ul) 69721squalene (200 ul)
10percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69723type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both90%pristane (150 ul) 69725pristane (150 ul)
10post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both16.9dsqualene (200 ul) 69789squalene (200 ul)
10post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both16.4dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69791type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both15.5dpristane (150 ul) 69793pristane (150 ul)

Contact Us |  About Us |  Jobs at RGD